Curevo is a Biotech company based in Seattle. It has raised $192M in total funding. Latest round: Series B.
Curevo funding overview
Curevo is a Biotech company based in Seattle. Curevo has raised $192M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series B announced in March 2025. The round record for Curevo runs through 2025; nothing later has been disclosed. Investors on record include Medicxi, OrbiMed, HBM Healthcare Investments, Sanofi Ventures, RA Capital Management, Janus Henderson Investors and 2 others. 8 distinct backers are named across the disclosed rounds.
Curevo at a glance
Total raised
$192M
Latest round
Series B
Latest round date
March 2025
Industry
Biotech
Headquarters
Seattle
Notable investors
Medicxi, OrbiMed, HBM Healthcare Investments, Sanofi Ventures, RA Capital Management, Janus Henderson Investors, Adjuvant Capital, GC Biopharma
Frequently asked about Curevo funding
How much has Curevo raised?
Curevo has raised $192M in total disclosed funding across the rounds on record.
Who has invested in Curevo?
Medicxi, OrbiMed, HBM Healthcare Investments, Sanofi Ventures, RA Capital Management, Janus Henderson Investors are named among the investors backing Curevo.
What was the latest Curevo funding round?
The most recent disclosed round is a Series B, announced in March 2025.
Where is Curevo based?
Curevo is based in Seattle.
What sector does Curevo operate in?
Curevo is tracked under Biotech from Seattle, with $192M in disclosed funding.
When did Curevo last raise?
The last disclosed Curevo round closed in March 2025 at Series B.
Curevo totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related Biotech companies in Seattle below to benchmark round size and investor mix.
